|
000
| 00895nas 2200217za 4500 |
|---|
| 001 | 9.506921 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20200331220131 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150406d19992000xxc|| m o||||f| |0eng|d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH42-2/3E-PDF |
|---|
| 110 | 1 |aCanada.|bHealth Canada. |bTherapeutic Products Directorate. |
|---|
| 245 | 10|aGuidance for industry |h[electronic resource] / |c[issued by the] Therapeutic Products Programme. |
|---|
| 246 | 1 |iAlternate title : |aTherapeutic Products Programme guidance document |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |
|---|
| 775 | 08|tLigne directrice à l'intention de l'industrie / |w(CaOODSP)9.500885 |
|---|
| 776 | 0#|tLigne directrice à l'intention de l'industrie / |w(CaOODSP)9.513090 |
|---|
| 776 | 0#|tGuidance for industry / |w(CaOODSP)9.514730 |
|---|
| 780 | 00|tTherapeutic Products Directorate guidelines |w(CaOODSP)9.506920 |
|---|